15 September 2015 - Deborah Wilkes
Archived
Perrigo is urging its shareholders to "take no action" after generics giant Mylan officially commenced its hostile takeover offer.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.